How much does a box of Bosutinib cost?

Bosutinib (Bosutinib) is a targeted drug used to treat chronic myelogenous leukemia (CML). As a representative of tyrosine kinase inhibitors, bosutinib blocks the growth and division of leukemia cells mainly by inhibiting the kinase activity of the BCR-ABL fusion protein.

Bosutinib is not yet available in China, so patients cannot purchase it domestically and need to purchase it through overseas channels. There are original drugs and generic drugs of bosutinib abroad. The original drugs include the Turkish original drug and the European version of the original drug. The Turkish version of the original drug costs about 2,000 to 3,000 yuan, and the European version of the original drug costs about 30,000 yuan. In addition, there are cheaper generic drugs, which cost more than one thousand yuan, and the ingredients of the original drugs and generic drugs are basically the same.

CMLis a type of leukemia caused by an abnormal geneBCR-ABL. The limitations of traditional treatment methods and the problem of drug resistance have prompted the development of targeted therapy drugs. As a second-generation tyrosine kinase inhibitor, bosutinib is more selective than first-generation drugs, such as imatinib, and more effectively inhibits abnormal kinase activity.

This drug is often used in patients with CML who have developed resistance or intolerance to other treatment options. The efficacy of bosutinib has been verified in clinical trials, helping to delay the development of leukemia and improve patient survival rates.

Although bosutinib is an important treatment tool, it can also cause a range of side effects, including digestive problems, fatigue, skin reactions, and more. Patients need to closely monitor these side effects during use and report to their doctors in a timely manner so that the treatment plan can be adjusted.